Menu
Back to User profile » Professor Erkan Topkan
Papers published by Professor Erkan Topkan:
Low Pre-ChemoradiotherapyPan-Immune-Inflammation Value (PIV) Measures Predict Better Survival Outcomes in Locally Advanced Pancreatic Adenocarcinomas
Topkan E, Selek U, Kucuk A, Pehlivan B
Journal of Inflammation Research 2022, 15:5413-5423
Published Date: 18 September 2022
High Measures of Pre-Chemoradiotherapy Platelet-to-Albumin Ratio Indicates Poor Prognosis in Locally Advanced Pancreatic Cancer Patients
Kucuk A, Topkan E, Selek U, Haksoyler V, Mertsoylu H, Besen AA, Pehlivan B
Therapeutics and Clinical Risk Management 2022, 18:421-428
Published Date: 14 April 2022
Pretreatment Systemic Immune-Inflammation Index Predict Needs for Teeth Extractions for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy
Yilmaz B, Somay E, Selek U, Topkan E
Therapeutics and Clinical Risk Management 2021, 17:1113-1121
Published Date: 18 October 2021
Novel Clinically Weight-Optimized Dynamic Conformal Arcs (WO-DCA) for Liver SBRT: A Comparison with Volumetric Modulated Arc Therapy (VMAT)
Saglam Y, Bolukbasi Y, Atasoy AI, Karakose F, Budak M, Alpan V, Topkan E, Selek U
Therapeutics and Clinical Risk Management 2021, 17:1053-1064
Published Date: 28 September 2021
The Prognostic Significance of Novel Pancreas Cancer Prognostic Index in Unresectable Locally Advanced Pancreas Cancers Treated with Definitive Concurrent Chemoradiotherapy
Topkan E, Selek U, Pehlivan B, Kucuk A, Haksoyler V, Kilic Durankus N, Sezen D, Bolukbasi Y
Journal of Inflammation Research 2021, 14:4433-4444
Published Date: 4 September 2021
High Pretreatment Platelet-to-Albumin Ratio Predicts Poor Survival Results in Locally Advanced Nasopharyngeal Cancers Treated with Chemoradiotherapy
Haksoyler V, Topkan E
Therapeutics and Clinical Risk Management 2021, 17:691-700
Published Date: 5 July 2021
Low Prognostic Nutritional Index Predicts Poor Clinical Outcomes in Patients with Stage IIIB Non-small-cell Lung Carcinoma Undergoing Chemoradiotherapy
Ozdemir Y, Topkan E, Mertsoylu H, Selek U
Cancer Management and Research 2020, 12:1959-1967
Published Date: 16 March 2020
Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical Chemoradiotherapy
Topkan E, Mertsoylu H, Ozdemir Y, Sezer A, Kucuk A, Besen AA, Ozyilkan O, Selek U
Cancer Management and Research 2019, 11:8807-8815
Published Date: 7 October 2019